RECRUITING

Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Screening for Atrial Fibrillation in Elderly Women (SAFE-W) is a pilot study evaluating the prevalence of atrial fibrillation (Afib) in a rapidly aging segment of the population. Studies have shown that women with Afib are more likely to be symptomatic, have increased mortality from stroke resulting from Afib, and are less likely to receive treatment for Afib. University of Maryland Department of Neurology and Vascular Neurology are recruiting women older than 70 years of age to participate in the study.

Official Title

Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years

Quick Facts

Study Start:2023-07-15
Study Completion:2025-07-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05444335

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:70 Years to 100 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Female sex
  2. 2. No previous diagnosis of atrial fibrillation
  3. 3. Age ≥70 years
  4. 4. CHA2DS2-VASc score ≥4
  1. 1. Life expectancy \< 2 years
  2. 2. Dementia or other neurologic condition which would make outpatient follow-up difficult
  3. 3. CHA2DS2-VASc score ≤3
  4. 4. Any compliance issues - such as heavy alcohol/drug use that would impede follow up.

Contacts and Locations

Study Contact

Prachi Mehndiratta, MBBS
CONTACT
410-328-4170
pmehndiratta@som.umaryland.edu
Seemant Chaturvedi, MD
CONTACT
410-328-5803
schaturvedi@som.umaryland.edu

Principal Investigator

Prachi Mehndiratta, MBBS
PRINCIPAL_INVESTIGATOR
University of Maryland, Baltimore

Study Locations (Sites)

University of Maryland Medical Center
Baltimore, Maryland, 21201
United States

Collaborators and Investigators

Sponsor: University of Maryland, Baltimore

  • Prachi Mehndiratta, MBBS, PRINCIPAL_INVESTIGATOR, University of Maryland, Baltimore

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-15
Study Completion Date2025-07-15

Study Record Updates

Study Start Date2023-07-15
Study Completion Date2025-07-15

Terms related to this study

Additional Relevant MeSH Terms

  • Atrial Fibrillation New Onset